PRISM BioLab Co.,LTD (TYO:206A)

Revenue by Product

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
Joint Development Projects	305.62M
Joint Development Projects Growth	385.68%

Revenue by Geography

Financials in millions JPY. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
United States	219.20M
United States Growth	1761.56%
Japan	69.63M
Japan Growth	2.34%
Switzerland	16.79M
Switzerland Growth	39.24%